California State Teachers Retirement System Amicus Therapeutics, Inc. Transaction History

California State Teachers Retirement System

  • $84.1 Billion
  • Q3 2024

A detailed history of California State Teachers Retirement System transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 215,335 shares of FOLD stock, worth $2.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
215,335
Previous 222,076 3.04%
Holding current value
$2.17 Million
Previous $2.2 Million 4.41%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$9.55 - $12.09 $64,376 - $81,498
-6,741 Reduced 3.04%
215,335 $2.3 Million
Q2 2024

Aug 14, 2024
SELL
$9.04 - $11.75 $65,829 - $85,563
-7,282 Reduced 3.17%
222,076 $2.2 Million
Q1 2024

May 15, 2024
SELL
$11.43 - $14.24 $108,036 - $134,596
-9,452 Reduced 3.96%
229,358 $2.7 Million
Q4 2023

Feb 13, 2024
SELL
$9.97 - $14.52 $117,057 - $170,479
-11,741 Reduced 4.69%
238,810 $3.39 Million
Q3 2023

Nov 14, 2023
SELL
$11.78 - $13.86 $345,271 - $406,236
-29,310 Reduced 10.47%
250,551 $3.05 Million
Q2 2023

Aug 21, 2023
SELL
$10.72 - $13.3 $84,184 - $104,444
-7,853 Reduced 2.73%
279,861 $3.52 Million
Q1 2023

May 09, 2023
SELL
$10.91 - $13.54 $59,274 - $73,562
-5,433 Reduced 1.85%
287,714 $3.19 Million
Q4 2022

Feb 14, 2023
BUY
$9.89 - $12.7 $34,011 - $43,675
3,439 Added 1.19%
293,147 $3.58 Million
Q3 2022

Nov 18, 2022
SELL
$9.82 - $12.75 $74,484 - $96,708
-7,585 Reduced 2.55%
289,708 $3.03 Million
Q2 2022

Aug 15, 2022
SELL
$6.23 - $11.12 $38,781 - $69,222
-6,225 Reduced 2.05%
297,293 $3.19 Million
Q1 2022

May 16, 2022
SELL
$7.89 - $12.48 $161,287 - $255,116
-20,442 Reduced 6.31%
303,518 $2.87 Million
Q4 2021

Feb 15, 2022
BUY
$9.82 - $12.44 $77,028 - $97,579
7,844 Added 2.48%
323,960 $3.74 Million
Q3 2021

Nov 15, 2021
SELL
$8.74 - $11.84 $404,871 - $548,476
-46,324 Reduced 12.78%
316,116 $3.02 Million
Q2 2021

Aug 16, 2021
SELL
$8.71 - $10.72 $231,555 - $284,991
-26,585 Reduced 6.83%
362,440 $3.49 Million
Q1 2021

May 18, 2021
SELL
$9.2 - $23.86 $2,953 - $7,659
-321 Reduced 0.08%
389,025 $3.84 Million
Q4 2020

Feb 16, 2021
BUY
$13.47 - $24.89 $60,386 - $111,581
4,483 Added 1.16%
389,346 $8.99 Million
Q3 2020

Nov 17, 2020
BUY
$12.89 - $15.89 $19,283 - $23,771
1,496 Added 0.39%
384,863 $5.43 Million
Q2 2020

Aug 17, 2020
SELL
$8.86 - $15.69 $48,916 - $86,624
-5,521 Reduced 1.42%
383,367 $5.78 Million
Q1 2020

May 13, 2020
SELL
$6.63 - $11.16 $12,776 - $21,505
-1,927 Reduced 0.49%
388,888 $3.59 Million
Q4 2019

Feb 14, 2020
SELL
$7.48 - $10.75 $59,054 - $84,871
-7,895 Reduced 1.98%
390,815 $3.81 Million
Q3 2019

Nov 15, 2019
BUY
$8.02 - $13.25 $338,179 - $558,712
42,167 Added 11.83%
398,710 $3.2 Million
Q2 2019

Aug 14, 2019
BUY
$10.96 - $14.4 $731,097 - $960,566
66,706 Added 23.02%
356,543 $4.45 Million
Q1 2019

May 09, 2019
SELL
$10.04 - $13.92 $64,707 - $89,714
-6,445 Reduced 2.18%
289,837 $3.94 Million
Q4 2018

Feb 13, 2019
BUY
$8.38 - $13.44 $55,986 - $89,792
6,681 Added 2.31%
296,282 $2.84 Million
Q3 2018

Nov 14, 2018
SELL
$11.6 - $16.54 $1,183 - $1,687
-102 Reduced 0.04%
289,601 $3.5 Million
Q2 2018

Aug 14, 2018
BUY
$13.13 - $17.09 $76,035 - $98,968
5,791 Added 2.04%
289,703 $4.53 Million
Q1 2018

May 15, 2018
BUY
$13.76 - $17.12 $284,666 - $354,178
20,688 Added 7.86%
283,912 $4.27 Million
Q4 2017

Feb 14, 2018
SELL
$12.51 - $16.24 $16,825 - $21,842
-1,345 Reduced 0.51%
263,224 $3.79 Million
Q3 2017

Nov 13, 2017
BUY
$11.74 - $15.78 $3.11 Million - $4.17 Million
264,569
264,569 $3.99 Million

Others Institutions Holding FOLD

# of Institutions
312
Shares Held
314M
Call Options Held
630K
Put Options Held
669K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.83B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email